Harmful biological pathogens, such as viruses, bacteria, fungi, protozoa, and worms, continue to pose a threat to the Joint Force. To combat these natural challenges and better defend warfighters from bioterrorism and biowarfare, the DTRA's Chemical and Biological Technologies Department in its role as the JSTO for the Chemical and Biological Defense Program collaborated with researchers at LLNL to create and evaluate a nanolipoprotein (NLP)-based multipathogen vaccine platform...